Turnstone Biologics
Business Services · Canada · 57 Employees
Turnstone is developing a disruptive class of engineered viral immunotherapies, attacking cancer's complexity with medicines designed to fight malignant disease at multiple points of intervention. Turnstone's proprietary vaccinia virus platform has been engineeredto stimulate the immune system, drive antigen presentation and recognition, and re-shape the tumor microenvironment. In addition, the large transgene capacity of the virus can be utilized to deliver other agents and therapeutics directly to sites of tumors throughout the body for local expression, reducing the potential for systemic toxicity. The company was founded in 2015 and their headquarters is in Ottawa, ON, Canada.Read More
Who is Turnstone Biologics
Headquarters
12 York St Fl 3, Ottawa, Ontario, K1N 5S6, Canada
Phone Number
(347) 897-5988
Website
Revenue
$19.2M
Industry
Turnstone Biologics's Social Media
Popular Searches
Turnstone Biologics
Turnstone Biologics Corp
Turnstone Biologics Inc
Turnstone Biologics| Corp
Turnstone Biologics| Inc
Top Competitors of Turnstone Biologics
Turnstone Biologics Org Chart
Phone
EmailPhoneEmail
Turnstone Biologics Company Metrics
Funding
Funding DateJul 21, 2021
RoundSeries D
Amount$80M
InvestorsPoint72, Eventide Asset Management, Surveyor Capital, PFM Health Sciences
Funding DateNov 01, 2016
RoundSeries B
Amount$41.4M
InvestorsVersant Ventures, F-Prime Capital Partners, OrbiMed, FACIT International AB
Funding DateOct 27, 2015
RoundSeries A
Amount$11.3M
InvestorsVersant Ventures
See More
$132.7M
Total Funding Amount
$80M
Most Recent Funding Amount
3
Number of Funding Rounds
Acquisitions & Subsidiaries
Sep 03, 2019
Myst Therapeutics
See More Acquisitions & Subsidiaries
Turnstone Biologics News & Media
Turnstone Biologics Enters Cooperative Research and Development Agreement with the National Cancer Institute to Study TIL Therapy in Combination with Viral Immunotherapy
SAN DIEGO--(BUSINESS WIRE)-- #NCI--Collaboration focused on potentiating the clinical benefit of TIL therapy against solid tumors through novel combinations with viral immunotherapy
Nov 29, 2022
Turnstone Biologics to Present Preclinical Data From Novel TIL Therapy Demonstrating Tumor-Reactive T-Cell Selection at the Society for Immunotherapy of Cancer (SITC) 37th Annual Meeting
SAN DIEGO--(BUSINESS WIRE)-- #SITC2022--Preclinical data support the clinical potential of Turnstone’s next-generation Selected TIL therapy to improve TIL efficacy against solid tumors.Nov 8, 2022Turnstone Biologics Announces FDA Clearance of IND for TIDAL-01, a Next-Generation TIL Therapy for Solid Tumors
SAN DIEGO--(BUSINESS WIRE)-- #SelectedTILs--Turnstone’s innovative approach with TIDAL-01 focuses on selecting and manufacturing the most potent tumor-reactive T-cells (Selected TILs).Oct 31, 2022Turnstone Biologics and Moffitt Cancer Center Announce Strategic Alliance to Advance Next-Generation TIL Therapies for Solid Tumors
NEW YORK & TAMPA, Fla.--(BUSINESS WIRE)-- #TIL--Strategic alliance significantly expands ongoing multi-year collaboration by granting Turnstone broader access and enhanced benefits at Moffitt.Jul 6, 2022Read more news
Frequently Asked Questions regarding Turnstone Biologics
Turnstone is developing a disruptive class of engineered viral immunotherapies, attacking cancer's complexity with medicines designed to fight malignant disease at multiple points of intervention. Turnstone's proprietary vaccinia virus platform has been engineered to stimulate the immune system, drive antigen presentation and recognition, and re-sh... Read More
Slide to rate Sammy Farah as a President & Chief Executive Officer
Trending Intent Signals Intent topics are topics that prospects are actively searching for online.
Find out what Turnstone Biologics is actively searching across the web.
Topic
Signal Score
Signal Score indicates how big the spike is compared to a company's historical baseline for consuming content.Digital Transformation
100
3 Signals found
Signal Location
North America
Date
2/7/23
Score
Audience
Candidate Sourcing
86
5 Signals found
Signal Location
North America
Date
2/7/23
Score
Audience
4.4/5 on G2 Crowd
Test Drive ZoomInfo's Directories
Browse Directories
